Vitamin E: supplement versus diet in neurodegenerative diseases

Jiang, 2003, γ-tocopherol, but not α-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats, FASEB J., 17, 816, 10.1096/fj.02-0877com Christen, 1997, γ-Tocopherol traps mutagenic electrophiles such as NOx and complements α-tocopherol: Physiological implications, Proc. Natl. Acad. Sci. U.S.A., 94, 3217, 10.1073/pnas.94.7.3217 Morris, 2005, Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change, Am. J. Clin. Nutr., 81, 508, 10.1093/ajcn.81.2.508 Huang, 2003, Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans, J. Nutr., 133, 3137, 10.1093/jn/133.10.3137 Miller, 2005, Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality, Ann. Intern. Med., 142, 37, 10.7326/0003-4819-142-1-200501040-00110 Petersen, 2005, Vitamin E and donepezil for the treatment of mild cognitive impairment, N. Engl. J. Med., 352, 2379, 10.1056/NEJMoa050151 1993, Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease, N. Engl. J. Med., 328, 176, 10.1056/NEJM199301213280305 Lloret, 2009, Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental, J. Alzheimers. Dis., 17, 143, 10.3233/JAD-2009-1033 Devore, 2010, Dietary antioxidants and long-term risk of dementia, Arch. Neurol., 67, 819, 10.1001/archneurol.2010.144 de Rijk, 1997, Dietary antioxidants and Parkinson disease. The Rotterdam Study, Arch. Neurol., 54, 762, 10.1001/archneur.1997.00550180070015